Clinical Trial Update: To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is assessing the long-term efficacy and safety of toludevenlafaxine hydrochloride sustained-release tablets for Major Depressive Disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Toludevenlafaxine hydrochloride sustained-release tablets (toludevenlafaxine hydrochloride)

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Major Depressive Disorder | Phase 4 | Status: NOT_YET_RECRUITING